VP and G-CSF With or Without Rituximab in Autologous Peripheral Stem Cell Transplant For NHL
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Rituximab
Related studies linked through entity extraction aliases.
Comparison Of Rituximab Versus Tositumomab and Iodine I 131 Tositumomab (BEXXAR® Therapeutic Regimen) For Patients With Relapsed Follicular Non-Hodgkins Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Immunopharmacological Effects of Rituximab in Atopic Dermatitis
- Status
- COMPLETED
- Phase
- NA
A Study of Retreatment With Rituximab in Patients With Rheumatoid Arthritis Receiving Background Methotrexate
- Status
- COMPLETED
- Phase
- PHASE3
Bortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Rituximab and GM-CSF in Treating Patients With Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Bortezomib, Rituximab and Dexamethasone (BORID) for Relapsed/Refractory Mantle Cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Rituximab Treatment to Block HLA Antibodies in Renal Transplant Recipients
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Rituximab in Active Ulcerative Colitis
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
RIMAG Study: Trial of Rituximab Versus Placebo in Polyneuropathy Associated With Anti-MAG IgM Monoclonal Gammopathy
- Status
- COMPLETED
- Phase
- PHASE3
A Pilot Study of the Use of Rituximab in the Treatment of Chronic Focal Encephalitis
- Status
- COMPLETED
- Phase
- PHASE1
Rituximab, Vaccine Therapy, and GM-CSF in Treating Patients With Non-Hodgkin's Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Rituximab and Cyclophosphamide in Treating Patients With High Risk, Refractory, or Relapsed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy Study of Rituximab in Renal Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
FCM-R (Fludarabine, Cyclophosphamide, Mitoxantrone, Rituximab) in Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL) < 70 Years
- Status
- COMPLETED
- Phase
- PHASE2
Fludarabine, Cyclophosphamide, and Rituximab Versus Pentostatin, Cyclophosphamide, and Rituximab in Previously Untreated or Treated B-Cell Chronic Lymphocytic Leukemia Patients
- Status
- COMPLETED
- Phase
- PHASE3
Use of Rituximab Treatment in Addition to Standard Care for Newly Presenting Thrombotic Thrombocytopenic Purpura
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Study of the Combination of Bortezomib, Dexamethasone, and Rituximab in Patients With Waldenstroms Macroglobulinemia
- Status
- COMPLETED
- Phase
- PHASE2
Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin (IL-2) vs. Rituximab Alone for Non-Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2